Search
Cancer cells have a sneaky ability to hide out in the body for years at a time. MSK scientists are looking for ways to flush them out.
Scientists at the Sloan Kettering Institute are learning how far-flung regions of genes connect to start the process of making proteins.
Biologists at Memorial Sloan Kettering Cancer Center have identified a set of genes expressed in human breast cancer cells that work together to remodel the network of blood vessels at the site of the primary tumor.
Read up on the progress being made in several key areas of cancer research, including immunotherapy, targeted therapy, precision surgery, and epigenetics.
The US Food and Drug Administration announced today that the drug ipilimumab (brand name Yervoy) has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.
What do you get when you combine two of the hottest areas of biotechnology? A new paper from MSK researchers explains.
Researchers from MSK and Weill Cornell have found that two compounds appear to fight off infection with the Zika virus.
A team of Memorial Sloan Kettering scientists has come up with an approach to make stem-cell-derived neurons rapidly age in a cell culture dish. The breakthrough could transform research into Parkinson’s and other late-onset diseases.
The breakthrough gives an unprecedented look at the varied and shifting poses of a protein in action.
Researchers are using pluripotent stem cells to create models of diabetes and pancreatic cancer.